To date, the GLP-1 Supply Tracker has generated more than 50,000 crowdsourced shortage reports and thousands of supply reports, data which Ro has shared with the FDA
Retatrutide adds a glucagon arm on top of GLP-1 and GIP, raising resting energy expenditure and hepatic lipid oxidation
Beyond obesity and type 2 diabetes, retatrutide is under investigation for related conditions such as nonalcoholic steatohepatitis (NASH)
Product Specifications Compound: Retatrutide 30mg Quantity: 30mg Form: Lyophilised research peptide Included: 3ml bacteriostatic water (for laboratory reconstitution only) Storage: Refrigerated per laboratory standards Important Research Use Notice This product is sold strictly for laboratory and scientific research use only
Phase 2 studies have shown that higher doses resulted in average weight reductions of around 24% after 48 weeks, with ongoing trials continuing to evaluate its effectiveness
Services, prices and nutrients may vary per location